Literature DB >> 12861079

Building a better Trap.

John D Hood1, David A Cheresh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12861079      PMCID： PMC166360          DOI： 10.1073/pnas.1633646100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  23 in total

1.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

Authors:  G Bergers; K Javaherian; K M Lo; J Folkman; D Hanahan
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

Review 2.  Molecular regulation of vessel maturation.

Authors:  Rakesh K Jain
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 3.  Fighting cancer by attacking its blood supply.

Authors:  J Folkman
Journal:  Sci Am       Date:  1996-09       Impact factor: 2.142

Review 4.  The biology of vascular endothelial growth factor.

Authors:  N Ferrara; T Davis-Smyth
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

5.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors:  K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 7.  Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.

Authors:  G Bergers; D Hanahan; L M Coussens
Journal:  Int J Dev Biol       Date:  1998       Impact factor: 2.203

8.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 9.  Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer.

Authors:  Nishan H Fernando; Herbert I Hurwitz
Journal:  Semin Oncol       Date:  2003-06       Impact factor: 4.929

10.  Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.

Authors:  Jianzhong Huang; Jason S Frischer; Anna Serur; Angela Kadenhe; Akiko Yokoi; Kimberly W McCrudden; Tamara New; Kathleen O'Toole; Stephanie Zabski; John S Rudge; Jocelyn Holash; George D Yancopoulos; Darrell J Yamashiro; Jessica J Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205
View more
  4 in total

Review 1.  Antibody Drug Conjugates: Preclinical Considerations.

Authors:  Gadi G Bornstein
Journal:  AAPS J       Date:  2015-02-28       Impact factor: 4.009

Review 2.  Antiangiogenic therapy for metastatic breast cancer: current status and future directions.

Authors:  Arlene Chan
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice.

Authors:  Rebecca Kinkade; Piyali Dasgupta; Adam Carie; Daniele Pernazza; Melanie Carless; Smitha Pillai; Nicholas Lawrence; Said M Sebti; Srikumar Chellappan
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 4.  Mechanisms and targets for angiogenic therapy after stroke.

Authors:  Deepti Navaratna; Shuzhen Guo; Ken Arai; Eng H Lo
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.